{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:37:27Z","timestamp":1779925047970,"version":"3.53.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"suppl_9","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI110375"],"award-info":[{"award-number":["R01 AI110375"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI100037"],"award-info":[{"award-number":["R01 AI100037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI106392"],"award-info":[{"award-number":["R21AI106392"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44AI118441"],"award-info":[{"award-number":["R44AI118441"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44AI128974"],"award-info":[{"award-number":["R44AI128974"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["272201600022C-0-0-1"],"award-info":[{"award-number":["272201600022C-0-0-1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI042853"],"award-info":[{"award-number":["P30AI042853"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI106716"],"award-info":[{"award-number":["UM1 AI106716"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12 HD000850"],"award-info":[{"award-number":["K12 HD000850"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1093\/infdis\/jix413","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T03:11:18Z","timestamp":1502766678000},"page":"S824-S828","source":"Crossref","is-referenced-by-count":23,"title":["Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance"],"prefix":"10.1093","volume":"216","author":[{"given":"Horacio A","family":"Duarte","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuttada","family":"Panpradist","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, University of Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A","family":"Beck","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Research Instituten"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Lutz","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, University of Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, University of Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M","family":"Kanthula","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases"},{"name":"Seattle Children\u2019s Research Instituten"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Kantor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubhav","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Center for Biomedical Engineering, School of Engineering"},{"name":"Alpert Medical School, Divisions of Biology and Medicine, Brown University, Providence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmugam","family":"Saravanan","sequence":"additional","affiliation":[{"name":"YRG CARE, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain J","family":"MacLeod","sequence":"additional","affiliation":[{"name":"Aldatu Biosciences, Harvard Life Lab"},{"name":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Global Health"},{"name":"Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Global Health, Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfu","family":"Yang","sequence":"additional","affiliation":[{"name":"Center for Global Health, Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M","family":"Frenkel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases"},{"name":"Seattle Children\u2019s Research Instituten"},{"name":"Department of Global Health"},{"name":"Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington"},{"name":"Department of Laboratory Medicine, Division of Virology, University of Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,13]]},"reference":[{"key":"key\n\t\t\t\t20180328135404_CIT0001","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/sti.2006.024265","article-title":"Rapid tests for sexually transmitted infections (STIs): the way forward","volume":"82","author":"Peeling","year":"2006","journal-title":"Sex Transm Infect"},{"key":"key\n\t\t\t\t20180328135404_CIT0002","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1093\/infdis\/jis044","article-title":"Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis","volume":"205","author":"Schito","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328135404_CIT0003","doi-asserted-by":"crossref","first-page":"e1001306","DOI":"10.1371\/journal.pmed.1001306","article-title":"Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries","volume":"9","author":"Pai","year":"2012","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180328135404_CIT0004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.bioeng.10.061807.160524","article-title":"Point-of-care diagnostics for global health","volume":"10","author":"Yager","year":"2008","journal-title":"Annu Rev Biomed Eng"},{"key":"key\n\t\t\t\t20180328135404_CIT0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328135404_CIT0006","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa1215541","article-title":"Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection","volume":"369","author":"Walmsley","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328135404_CIT0007","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1473-3099(13)70257-3","article-title":"Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial","volume":"13","author":"Raffi","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328135404_CIT0008","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(14)60084-2","article-title":"Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study","volume":"383","author":"Clotet","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328135404_CIT0009","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/jac\/dkw071","article-title":"Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors","volume":"71","author":"Brenner","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328135404_CIT0010","volume-title":"Pathways of resistance in subjects failing dolutegravir monotherapy","author":"Blanco","year":"2017"},{"key":"key\n\t\t\t\t20180328135404_CIT0011","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1128\/AAC.01835-13","article-title":"Biochemical analysis of the role of G118R-linked dolutegravir drug resistance substitutions in HIV-1 integrase","volume":"57","author":"Quashie","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328135404_CIT0012","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/JVI.03353-14","article-title":"Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase","volume":"89","author":"Quashie","year":"2015","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180328135404_CIT0013","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1093\/jac\/dku095","article-title":"New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors","volume":"69","author":"Malet","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328135404_CIT0014","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/jac\/dku474","article-title":"G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistance","volume":"70","author":"Munir","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328135404_CIT0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QAI.0000000000000312","article-title":"Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya","volume":"67","author":"Chung","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328135404_CIT0016","volume-title":"Prospective randomized HIV drug resistance testing of Kenyans before first-line ART","author":"Chung"},{"key":"key\n\t\t\t\t20180328135404_CIT0017","volume-title":"Impact of pre-treatment HIV-drug resistance on virologic outcome of first-line art","author":"Beck","year":"2017"},{"key":"key\n\t\t\t\t20180328135404_CIT0018","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1128\/JCM.33.2.342-347.1995","article-title":"Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine","volume":"33","author":"Frenkel","year":"1995","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328135404_CIT0019","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/JCM.40.4.1413-1419.2002","article-title":"Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors","volume":"40","author":"Beck","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328135404_CIT0020","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/QAI.0b013e31817ed7d7","article-title":"Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants","volume":"48","author":"Beck","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328135404_CIT0021","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/652151","article-title":"Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine","volume":"50","author":"Micek","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328135404_CIT0022","doi-asserted-by":"crossref","first-page":"e0145962","DOI":"10.1371\/journal.pone.0145962","article-title":"Simplified paper format for detecting HIV drug resistance in clinical specimens by oligonucleotide ligation","volume":"11","author":"Panpradist","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328135404_CIT0023","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.aids.0000222071.60620.1d","article-title":"Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission","volume":"20","author":"Loubser","year":"2006","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328135404_CIT0024","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1073\/pnas.0602033103","article-title":"Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission","volume":"103","author":"Palmer","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180328135404_CIT0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/QAD.0b013e32832e5303","article-title":"Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy","volume":"24","author":"Paredes","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328135404_CIT0026","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2010.10.001","article-title":"Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-na\u00efve patients","volume":"50","author":"Metzner","year":"2011","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20180328135404_CIT0027","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/infdis\/jit635","article-title":"Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP","volume":"209","author":"Boltz","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328135404_CIT0028","unstructured":"Saravanan S , DineshaT, PoongulaliS A point mutation resistance assay to optimize HIV-1 subtype C antiretroviral therapy in India. In: 21st International AIDS Conference, Durban, South Africa, 2016."},{"key":"key\n\t\t\t\t20180328135404_CIT0029","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1128\/JCM.01669-13","article-title":"Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay","volume":"51","author":"Zhang","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328135404_CIT0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/JCM.02833-15","article-title":"Simultaneous detection of major drug resistance mutations of HIV-1 subtype B viruses from dried blood spot specimens by multiplex allele-specific assay","volume":"54","author":"Zhang","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328135404_CIT0031","unstructured":"Beard R , DuongY, MaphalalaG National prevalence of transmitted HIV drug resistance in Swaziland in 2011. In: 20th International AIDS Conference, Melbourne, Australia, 2014."},{"key":"key\n\t\t\t\t20180328135404_CIT0032","unstructured":"Zhang G , GuoH, DeVosJ A sensitive and single-tube detection assay for identifying HIV-1 drug-resistance mutations associated with pre-exposure prophylaxis. In: 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 2013."},{"key":"key\n\t\t\t\t20180328135404_CIT0033","doi-asserted-by":"crossref","DOI":"10.3390\/v8020048","article-title":"Genetic variability of HIV-1 for drug resistance assay development","volume":"8","author":"Clutter","year":"2016","journal-title":"Viruses"},{"key":"key\n\t\t\t\t20180328135404_CIT0034","doi-asserted-by":"crossref","first-page":"e0145772","DOI":"10.1371\/journal.pone.0145772","article-title":"HIV-1 drug resistance mutations: potential applications for point-of-care genotypic resistance testing","volume":"10","author":"Rhee","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328135404_CIT0035","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jmoldx.2015.07.001","article-title":"One-step ligation on RNA amplification for the detection of point mutations","volume":"17","author":"Zhang","year":"2015","journal-title":"J Mol Diagn"},{"key":"key\n\t\t\t\t20180328135404_CIT0036","volume-title":"Kinetics, mass transport, and adsorption in diagnostic microfluidic devices","author":"McCalla","year":"2012"},{"key":"key\n\t\t\t\t20180328135404_CIT0037","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jmoldx.2013.02.005","article-title":"Detection of HIV-1 minority variants containing the K103N drug-resistance mutation using a simple method to amplify RNA targets (SMART)","volume":"15","author":"Morabito","year":"2013","journal-title":"J Mol Diagn"},{"key":"key\n\t\t\t\t20180328135404_CIT0038","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S1473-3099(16)30118-9","article-title":"Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa","volume":"16","author":"Inzaule","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328135404_CIT0039","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/POC.0000000000000056","article-title":"Barriers to implementation of rapid and point-of-care tests for human immunodeficiency virus infection: findings from a systematic review (1996\u20132014)","volume":"14","author":"Pai","year":"2015","journal-title":"Point Care"},{"key":"key\n\t\t\t\t20180328135404_CIT0040","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1093\/infdis\/jis203","article-title":"Perspectives on introduction and implementation of new point-of-care diagnostic tests","volume":"205","author":"Palamountain","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328135404_CIT0041","author":"M\u00e9dicins Sans Fronti\u00e8res","year":"2015"},{"key":"key\n\t\t\t\t20180328135404_CIT0042","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0040-2016","article-title":"Impact of the GeneXpert MTB\/RIF technology on tuberculosis control","volume":"5","author":"Stevens","year":"2017","journal-title":"Microbiol Spectr"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_9\/S824\/24264813\/jix413.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T05:34:35Z","timestamp":1659332075000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/216\/suppl_9\/S824\/4523968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,13]]},"references-count":42,"journal-issue":{"issue":"suppl_9","published-online":{"date-parts":[[2017,10,13]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix413","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11,15]]},"published":{"date-parts":[[2017,10,13]]}}}